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Extracellular calcification is a common and clinically significant component of a number of important human 
diseases including atherosclerosis. Myocardial infarction in most instances is the consequence of a thrombus forming on 
a ruptured atherosclerotic plaque, which is frequently associated with calcification. Coronary calcification in 
asymptomatic patients is known to increase the risk of coronary heart disease (CHD), and mineral deposits are found in 
more than 90% of patients with CHD. Recent studies suggest that in addition to modifiable coronary risk factors, such 
as hypertension, hyperlipidemia, and cigarette smoking, there is a strong genetic background for development of arterial 
calcification. The role of genetic predisposition to coronary artery calcification has been estimated to be up to 50%. 
Matrix γ-carboxyglutamic acid protein (MGP) is known to be a potent inhibitor of calcification in blood vessels and is 
strongly expressed on calcified atherosclerotic plaques in humans; it could modify the calcification in such plaques and 
the risk CHD. The human gene MGP is located on chromosome 12p. At present, among the large amount of identified 
MGP single nucleotide polymorphisms (SNPs) 8 of them are under the most intensive investigation: 2 of them in exons, 
and 6 in the upstream region of the gene. In vitro studies suggest that SNPs in MGP are associated with altered 
promoter activity. In addition, there is some evidence that MGP SNPs are associated with arterial calcification, although 
these results are not consistent.The purpose of this study was to investigate the association of three variants of MGP 
SNPs (G-7A, T-138C, Thr83Ala) with acute coronary syndrome (ACS) in Ukrainian population. Polymerase chain 
reaction and restriction fragment length polymorphism (RFLP) analysis were used to detect the above mentioned 
variants of MGP gene in 115 patients with acute coronary syndrome and in 110 practically 
healthyindividuals.Distribution of major allele homozygotous, heterozygotes and minor allele homozygotes in control 
group while analyzing T
-138→Сpromoter polymorphism58,7%, 36,7%, 4,6 while analyzing G-7→A polymorphism of 
the promoter was - 41,8%, 54,5%, 3,6% , while at the assay of Thr83→Ala polymorphism (exon 4) these were – 43,9%, 
45,9%, 10,2%. Distribution of major allele homozygotous, heterozygotes and minor allele homozygotes  in group with 
acute coronary syndrome: while analyzing T
-138→СMGP promoter polymorphism were 59,8%, 32,7%, 7,5%, while 
analyzing G
-7→A promoter polymorphism were - 42,1%, 45,6%, 12,3% , while at the assay of Thr83→Ala 
polymorphism (exon 4) these were– 42,6%, 43,5%, 13,9%.  It was estimated that A/A genotype (G-7→A 
polymorphism) was significantly (p=0,02) associated with acute coronary syndrome in Ukrainian population. 
 
